CLLS Overview
Upcoming Projects (CLLS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CLLS)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (CLLS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CLLS)
-
Cellectis (CLLS) Subsidiary acquires land for mid-2017 manufacturing facility
Ticker: CLLS
Occurred on: Aug 02, 2017 -
Juno Therapeutics (JUNO) Suspends Phase 2 ROCKET Study Assessing JCAR015 in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Tickers: JUNO, KITE, CLLS
Occurred on: Nov 23, 2016 -
Cellectis (CLLS) Announces RetroNectin® Supply and License Agreement with Takara Bio Inc
Ticker: CLLS
Occurred on: Mar 21, 2016 -
Cellectis (CLLS) and MabQuest Announce Immunotherapy Partnership on New Class of PD-1 Antagonist Monoclonal Antibodies
Ticker: CLLS
Occurred on: Mar 16, 2016 -
NIH study results of off-the-shelf CAR-Ts pose threat to designer CAR-T producers Kite Pharma (KITE) and Juno Therapeutics (JUNO)
Tickers: KITE, CLLS, JUNO
Occurred on: Jan 26, 2016 -
Cellectis (CLLS) signs agreement with CELLforCURE for the cGMP Manufacturing of UCART123 for Hematological Malignancies
Ticker: CLLS
Occurred on: Jan 16, 2016 -
Cellectis (CLLS) announces new CAR architecture with an integrated switch-on system for CAR T-cell functions
Ticker: CLLS
Occurred on: Jan 11, 2016 -
Cellectis Announces a New CAR Architecture Controlling CAR T-Cell Functions
Ticker: CLLS
Occurred on: Jan 11, 2016 -
Cellectis (CLLS) files CTA for UCART19, an Allogeneic Gene Edited CAR T-Cell Product for Hematological Malignancies
Ticker: CLLS
Occurred on: Dec 23, 2015
Strategic Initiatives (CLLS)
-
Cellectis (CLLS) Announces Increase in Production of UCART123 T-Cell Therapy Candidate for Acute Myeloid Leukemia (AML) and Other Cancers
Ticker: CLLS
Announcement Date: Nov 16, 2016
